From Saurashtra's Fields to the Clinic: Cactose Bets on Cactus Fruit to Crack India's Anaemia Crisis

India has run iron supplementation programmes since the 1970s, yet the country carries one of the heaviest anaemia burdens in the world. According to Cactose, 57% of women between the ages of 15 and 49 remain anaemic, as do 52% of pregnant women and 67% of children under five — figures that have resisted five decades of policy effort.

The startup argues the failure is not one of awareness or availability, but of delivery. Conventional iron supplements, most commonly formulated as ferrous sulfate tablets, are associated with metallic taste, nausea, and constipation. According to Cactose, more than half of patients quietly discontinue treatment because of these side effects — a compliance gap that national programmes have historically not tracked. The system, the company contends, has measured prescription rates while overlooking whether patients actually complete their course.

Cactose's answer to this compliance crisis originates in an unlikely agricultural source: cactus fruit growing in the fields of Saurashtra, Gujarat. The startup describes itself as developing India's first cactus-based herbal drink for iron supplementation, positioning the product as a functional, ready-to-drink format rather than a pill or powder.

The formulation combines plant-based iron sources — including prickly pear and curry leaf — with absorption-supporting cofactors such as Vitamin C. The company argues that iron derived from whole-food sources behaves differently from synthetic ferrous sulfate because it arrives alongside natural compounds that support uptake by the body. Cactose frames this as a bioavailability argument: the relevant question for consumers is not merely how much iron is in a supplement, but how much the body can actually absorb and utilise. The ready-to-drink format is designed specifically to reduce the friction that causes patients to abandon conventional supplements.

Cactose is not positioning itself solely as a consumer health brand. The startup has outlined a partnership-led distribution strategy targeting three distinct channels:

• Doctors and healthcare providers, to build clinical credibility and ensure evidence-backed deployment
• CSR and NGO leaders, to extend reach into communities where anaemia is most prevalent
• Government and health workers, to integrate the product into existing community health programmes

This approach reflects the scale of the problem Cactose is addressing. Anaemia disproportionately affects women of reproductive age, pregnant women, children, cancer patients undergoing chemotherapy, and regular blood donors — populations that are often served through public health infrastructure rather than retail pharmacy channels. By targeting institutional and programme-level partnerships alongside direct consumer outreach, the startup is seeking to position Cactose Wellness as both a commercial product and a public health tool.

Beyond its health claims, Cactose carries a distinct agricultural dimension. Cactus fruit — specifically prickly pear — is currently underutilised in Saurashtra, the semi-arid peninsula in western Gujarat. By building a commercial supply chain around this crop as a primary ingredient, Cactose could, if it scales, create incremental demand and potentially new income opportunities for farmers in the region who currently have limited market access for the fruit.

The startup's narrative — from an underutilised field crop to a science-backed functional beverage — mirrors a broader trend in Indian agri-food entrepreneurship, where startups are seeking to add value to neglected or underprocessed agricultural produce. Whether Cactose can build a procurement model that is both commercially viable and beneficial to Saurashtra's farming communities will be a key variable in assessing its long-term impact beyond the health sector.